Atlas Trials

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma

Clinical trial NCT06031636 · UNKNOWN

Trial details

NCT number
NCT06031636
Sponsor
Tianjin Medical University Second Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Malignant Pleural Mesothelioma, Advanced
Start date
2023-07-20
Primary completion
2026-07-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.